Predict your next investment

Nitrome Biosciences company logo
HEALTHCARE | Drug Development
nitromebiosciences.com

See what CB Insights has to offer

Executives

1

Board of Directors

1

Nitrome Biosciences Board of Director

1 Board of directors

Nitrome Biosciences has 1 board of directors, including Margarita Chavez.

Name

Firm

Work History

Other Seats

Margarita Chavez

Margarita has lead investments in over a dozen biotech companies in the US and Europe. She is responsible for AbbVie Ventures’ investments in Alector (NASDAQ: ALEC), Morphic Therapeutics (NASDAQ: MORF) and Jnana Therapeutics, among others, and serves on the Boards of Carisma Therapeutics, Magnolia Neurosicences, Rodeo Therapeutics and Nitrome Biosciences. Beyond AbbVie Ventures, Margarita also serves on the Boards of the New England Venture Capital Association, the MidAmerica Healthcare Investors Network and P33 Chicago. Margarita brings over 20 years of dealmaking leadership. As a Director of Abbott’s Global Pharmaceutical Licensing & Acquisitions, she was involved in the in-licensing of Elagolix, the acquisition of Solvay and Immuven, and the acquisition of the Lupron franchise. Before joining Abbott, Margarita practiced as a corporate and securities lawyer in Silicon Valley with the firm of Brobeck Phleger & Harrison. Margarita holds a bachelor’s degree from Santa Clara University and a Juris Doctor from Santa Clara University School of Law.

Nitrome Biosciences

Name

Margarita Chavez

Firm

Work History

Margarita has lead investments in over a dozen biotech companies in the US and Europe. She is responsible for AbbVie Ventures’ investments in Alector (NASDAQ: ALEC), Morphic Therapeutics (NASDAQ: MORF) and Jnana Therapeutics, among others, and serves on the Boards of Carisma Therapeutics, Magnolia Neurosicences, Rodeo Therapeutics and Nitrome Biosciences. Beyond AbbVie Ventures, Margarita also serves on the Boards of the New England Venture Capital Association, the MidAmerica Healthcare Investors Network and P33 Chicago. Margarita brings over 20 years of dealmaking leadership. As a Director of Abbott’s Global Pharmaceutical Licensing & Acquisitions, she was involved in the in-licensing of Elagolix, the acquisition of Solvay and Immuven, and the acquisition of the Lupron franchise. Before joining Abbott, Margarita practiced as a corporate and securities lawyer in Silicon Valley with the firm of Brobeck Phleger & Harrison. Margarita holds a bachelor’s degree from Santa Clara University and a Juris Doctor from Santa Clara University School of Law.

Other Seats

Nitrome Biosciences

Nitrome Biosciences Management Team

1 Team Member

Nitrome Biosciences has 1 executive. Nitrome Biosciences's current Founder, Chief Executive Officer is Irene Griswold-Prenner.

Name

Work History

Title

Status

Irene Griswold-Prenner

Elan, and UCLA

Founder, Chief Executive Officer

Current

Name

Irene Griswold-Prenner

Work History

Elan, and UCLA

Title

Founder, Chief Executive Officer

Status

Current

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.